Orchestra BioMed Holdings, Inc. (OBIO) Financials
OBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 100.7 million | 49.7 million |
| Dec. 31, 2025 | 114.9 million | 51.5 million |
| Sept. 30, 2025 | 104.8 million | 61.1 million |
| June 30, 2025 | 42.8 million | 42.5 million |
OBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -22.4 million | 2.9 million |
| Dec. 31, 2025 | -2.3 million | 2.8 million |
| Sept. 30, 2025 | -14.9 million | 3.0 million |
| June 30, 2025 | -15.6 million | 3.3 million |
OBIO Net Income
No data available :(
OBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 94.4 million | - | 730000 |
| Dec. 31, 2025 | 106.5 million | 30.8 million | 936000 |
| Sept. 30, 2025 | 95.8 million | 14.2 million | 1.8 million |
| June 30, 2025 | 33.9 million | 14.4 million | 2.0 million |
OBIO Shares Outstanding
OBIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 184000 | 15.8 million | 6.3 million | - |
| Dec. 31, 2025 | 33000 | 16.8 million | 7.3 million | - |
| Sept. 30, 2025 | 310000 | 14.0 million | 7.1 million | - |
| June 30, 2025 | 34000 | 13.9 million | 6.3 million | - |
OBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 110000 | 92000 |
| Dec. 31, 2025 | 30.9 million | 51000 |
| Sept. 30, 2025 | 861000 | 49000 |
| June 30, 2025 | 836000 | 46000 |
OBIO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
OBIO
Price: $3.85
52 week price:
Earnings Per Share: -0.95 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 233.5 million